Both in Pharmaceuticals
Perspective Therapeutics vs NRX Pharmaceuticals
Over the past year CATX returned −62.7% and NRXP returned −9.1%; their daily moves had a correlation of 0.13.
CATX −62.7% NRXP −9.1%Growth of $1, one year, split-adjusted
| Metric | CATX | NRXP |
|---|---|---|
| Price | $0.8702 | $2.49 |
| Market cap | $99.3M | $107.8M |
| Today | −1.11% | +11.16% |
| 1 month | −63.1% | −15.3% |
| 6 months | −77.2% | −18.4% |
| Year to date | −68.4% | −8.1% |
| 1 year | −66.5% | −12.6% |
| Revenue growth (YoY) | −72.1% | — |
| Gross margin | 100.0% | 38.7% |
| Net margin | −33069.1% | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | 242.9× | 31.8× |
| Net cash | $235.3M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 117.1% | 61.5% |
| Short % of float | 17.1% | 29.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).